Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
© Zhang et al; licensee BioMed Central Ltd. 2013
Received: 17 May 2012
Accepted: 2 January 2013
Published: 2 January 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|17 May 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|9 Jun 2012||Reviewed||Reviewer Report - Daniel Petrovic|
|20 Jul 2012||Reviewed||Reviewer Report - Alisa Manning|
|29 Aug 2012||Author responded||Author comments - Tengyue Zhang|
|Resubmission - Version 3|
|29 Aug 2012||Submitted||Manuscript version 3|
|5 Sep 2012||Reviewed||Reviewer Report - Daniel Petrovic|
|10 Oct 2012||Reviewed||Reviewer Report - Alisa Manning|
|29 Oct 2012||Author responded||Author comments - Tengyue Zhang|
|Resubmission - Version 4|
|29 Oct 2012||Submitted||Manuscript version 4|
|24 Nov 2012||Author responded||Author comments - Tengyue Zhang|
|Resubmission - Version 5|
|24 Nov 2012||Submitted||Manuscript version 5|
|2 Jan 2013||Editorially accepted|
|2 Jan 2013||Article published||10.1186/1741-7015-11-1|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.